Biology Reference
In-Depth Information
[69] Gallardo D, Arostegui JI, Balas A, Torres A, Caballero D, Carreras E, et al. Disparity
for the minor histocompatibility antigen HA-1 is associated with an increased risk of
acute graft-versus-host disease (GVHD) but it does not affect chronic GVHD incidence,
disease-free survival or overall survival after allogeneic human leucocyte antigen-iden-
tical sibling donor transplantation. Br J Haematol 2001;114:931-6.
[70] Spellman S, Warden MB, Haagenson M, Pietz BC, Goulmy E, Warren III EH, et al. Effects
of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-
matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant
2009;15:856-63.
[71] Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E. Graft-versus-
host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in
chronic myeloid leukemia patients. Leukemia 2010;24:1388-92.
[72] Ryan M, Diekhans M, Lien S, Liu Y, Karchin R. LS-SNP/PDB: annotated non-synony-
mous SNPs mapped to Protein Data Bank structures. Bioinformatics 2009;25:1431-2.
[73] Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, Li K, et al. Genetic variation in an
individual human exome. PLoS Genet 2008;4:e1000160.
[74] de Beuger M, Bakker A, van Rood JJ, Van der WF, Goulmy E. Tissue distribution of hu-
man minor histocompatibility antigens. Ubiquitous versus restricted tissue distribu-
tion indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC
antigens. J Immunol 1992;149:1788-94.
[75] Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, et al.
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor
histocompatibility antigens. Nat Med 2002;8:410-4.
[76] Kim YH, Vyth-Dreese FA, Schrama E, Pavel S, Bajema I, Goulmy E, et al. Exogenous
addition of minor H antigen HA-1+ dendritic cells to skin tissues ex vivo causes infiltra-
tion and activation of HA-1-specific cytotoxic T cells. Biol Blood Marrow Transplant
2011;17:69-77.
[77] Wilke M, Pool J, den Haan JM, Goulmy E. Genomic identification of the minor histo-
compatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 1998;52:312-7.
[78] Goulmy E. Human minor histocompatibility antigens: new concepts for marrow trans-
plantation and adoptive immunotherapy. Immunol Rev 1997;157:125-40.
[79] Klein CA, Wilke M, Pool J, Vermeulen C, Blokland E, Burghart E, et al. The hematopoi-
etic system-specific minor histocompatibility antigen HA-1 shows aberrant expression
in epithelial cancer cells. J Exp Med 2002;196:359-68.
[80] Torikai H, Akatsuka Y, Yatabe Y, Morishima Y, Kodera Y, Kuzushima K, et al. Aberrant
expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells:
application for allogeneic transplantation. Int J Hematol 2008;87:467-73.
[81] Overes IM, Levenga TH, Vos JC, van Horssen-Zoetbrood A, van d V, De Mulder PH, et al.
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen
LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis. Cancer Im-
munol Immunother 2009;58:429-39.
[82] Dolstra H, Fredrix H, Maas F, Coulie PG, Brasseur F, Mensink E, et al. A human minor
histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med
1999;189:301-8.
[83] Torikai H, Akatsuka Y, Miyauchi H, Terakura S, Onizuka M, Tsujimura K, et al.
The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can
also be presented by another HLA-A2 subtype, A*0206. Bone Marrow Transplant
2007;40:165-74.
[84] Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-
Heys SA, et al. Identification of phosphatidylinositol 4-kinase type II beta as HLA
class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci USA
2008;105:3837-42.
[85] Slager EH, Honders MW, van der Meijden ED, van Luxemburg-Heys SA, Kloosterboer
FM, Kester MG, et al. Identification of the angiogenic endothelial-cell growth factor-1/
thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood
2006;107:4954-60.
[86] Torikai H, Akatsuka Y, Miyazaki M, Tsujimura A, Yatabe Y, Kawase T, et al. The hu-
man cathepsin H gene encodes two novel minor histocompatibility antigen epitopes
restricted by HLA-A*3101 and -A*3303. Br J Haematol 2006;134:406-16.
[87] Van Bergen CA, Kester MG, Jedema I, Heemskerk MH, Van Luxemburg-Heijs SA,
Kloosterboer FM, et al. Multiple myeloma-reactive T cells recognize an activation-
induced minor histocompatibility antigen encoded by the ATP-dependent interferon-
responsive (ADIR) gene. Blood 2007;109:4089-96.
[88] Warren III EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, Loeb KR, et al. Therapy of re-
lapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific
for minor histocompatibility antigens. Blood 2010;115:3869-78.
56
Search WWH ::
Custom Search